Search - tctmd.com

Displaying 941 - 960 of 1352

Sort: Relevancy | Date

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Jason Kahn

November 06, 2012

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Conference News AHA 2012

Cell Therapy Trials Show Mixed Results at AHA 2012

November 05, 2012

News Conference News AHA 2012

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Jason Kahn

November 04, 2012

News Conference News AHA 2012

Platelet Reactivity in Response to Prasugrel Depends on the Test

November 04, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Conference News AHA 2012

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Jason Kahn

November 04, 2012

News Conference News TCT 2012

Biomarkers May Identify Risky Subcritical Lesions

October 30, 2012

News Conference News TCT 2012

Shift in Paradigm for HF Monitoring Needed

October 26, 2012

News Conference News TCT 2012

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

October 25, 2012

News Conference News TCT 2012

Novel Devices Provide Options for LAA Therapy

October 25, 2012

News Industry News

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

October 25, 2012

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Conference News TCT 2012

Presentations Examine Multiple Facets of Antiplatelet Agents

October 24, 2012

News Conference News TCT 2012

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

October 24, 2012

News Conference News TCT 2012

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

October 24, 2012

Presentation TCT 2012

TCT-20. IVUS Predictors of Stent Thrombosis: Results from the Prospective, Multicenter ADAPT-DES Study

Presenter: Akiko Maehara

October 23, 2012

News Conference News TCT 2012

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

October 23, 2012

News Conference News TCT 2012

Registries Demonstrate Positive Long-Term Outcomes with TAVR

October 23, 2012

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

Advertisement

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Evidence Continues to Support Dabigatran Treatment in A-fib

Cell Therapy Trials Show Mixed Results at AHA 2012

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Platelet Reactivity in Response to Prasugrel Depends on the Test

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Biomarkers May Identify Risky Subcritical Lesions

Shift in Paradigm for HF Monitoring Needed

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

Novel Devices Provide Options for LAA Therapy

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

Presentations Examine Multiple Facets of Antiplatelet Agents

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

TCT-20. IVUS Predictors of Stent Thrombosis: Results from the Prospective, Multicenter ADAPT-DES Study

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

Registries Demonstrate Positive Long-Term Outcomes with TAVR

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content